4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-13-027083
CIK 0001069308operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 2:49 PM ET
Size
5.4 KB
Accession
0001140361-13-027083
Insider Transaction Report
Form 4
Warma Neil K
President & CEO
Transactions
- Award
Common Stock
2013-06-30$1.54/sh+581$895→ 9,239 total
Footnotes (1)
- [F1]On June 30, 2013, the reporting person was issued 581 shares of Common Stock as payment-in-kind for interest accrued as of June 30, 2013 on a 12% Convertible Secured Promissory Note held in the principal amount of $15,000. The shares issued in payment of accrued interest payable on the interest payment date were deemed to have a value equal to the volume weighted average price for the Common Stock for the five trading days ending three trading days prior to the payment date.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 2:49 PM ET
- Size
- 5.4 KB